|Bid||11.11 x 28000|
|Ask||11.12 x 4000|
|Day's Range||10.89 - 11.29|
|52 Week Range||8.25 - 31.58|
|Beta (5Y Monthly)||1.76|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan 21, 2021 - Jan 25, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Feb 04, 2020|
|1y Target Est||11.16|
New, daily, U.S. coronavirus cases hit 80,000 on Thursday, with Regeneron posting positive results from its antibody cocktail trial, Moderna saying it is ‘actively preparing’ for a global launch of it vaccine, and Gilead announcing it sold $873 million dollars worth of its antiviral treatment. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.
Yahoo Finance’s Kristin Myers and ETF Trends CEO Tom Lydon discuss how the coronavirus is weighing on the airline industry.
Tepid passenger revenues induce losses for the likes of American Airlines (AAL), Southwest Airlines (LUV) and Alaska Air Group (ALK) in third-quarter 2020.